Targeting Mitochondrial Complex I Protects Against Palmitic Acid–Induced Endothelial Dysfunction
Diabetes, Obesity and Metabolism · 2026
DOI: 10.1111/dom.71164 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2026. Verfasst von Chenxia Zhou und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Palmitic Acid, Electron Transport Complex I, Endothelium, Vascular, Mitochondria. Die Arbeit nennt 41 Literaturangaben. Gefördert von: Academic Leaders Training Program of Pudong Health Bureau of Shanghai, Medical Discipline Construction Program of Shanghai Pudong New Area Health Commission, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Endothelial dysfunction induced by elevated free fatty acids is a critical initiating event in diabetic macrovascular complications. While mitochondrial reactive oxygen species (mtROS) are key mediators of this lipotoxic injury, the specific contribution of mitochondrial Complex I dynamics and its associated redox regulation remains to be fully elucidated.
Methods
We investigated the therapeutic potential of targeting mitochondrial Complex I in lipotoxicity‐induced endothelial injury. Using rotenone (a Complex I inhibitor) and NDUFS4 [NADH Dehydrogenase (Ubiquinone) Fe‐S Protein 4]‐targeting siRNA, we performed in vitro interventions in palmitic acid‐treated human aortic endothelial cells and in vivo studies in high‐fat diet (HFD)‐fed mice.
Results
Palmitic acid triggered endothelial dysfunction accompanied by pronounced mitochondrial oxidative stress. Mechanistically, palmitic acid lowered the oxidised/reduced nicotinamide adenine dinucleotide (NAD + /NADH) ratio and increased NADH‐linked Complex I activity, a redox state consistent with enhanced Complex I‐linked ROS generation. Pharmacological (rotenone) or genetic ( NDUFS4 knockdown) modulation of Complex I activity suppressed mtROS overproduction, improved NAD + /NADH balance, alleviated oxidative stress and improved endothelial function. In vivo, rotenone attenuated HFD‐induced systemic metabolic disturbances and vascular oxidative stress while improving endothelial barrier integrity and angiogenic responses.
Conclusions
Our study suggests that dysregulated mitochondrial Complex I activity may serve as an important contributor to lipotoxic endothelial injury. These findings support Complex I modulation as a potential strategy to mitigate free fatty acid‐induced endothelial dysfunction in obesity‐ and diabetes‐related vascular complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.
ORCID-Profile: Chenxia Zhou, Ruoxuan Li
Förderung
- Academic Leaders Training Program of Pudong Health Bureau of Shanghai
- Medical Discipline Construction Program of Shanghai Pudong New Area Health Commission
- National Natural Science Foundation of China
Zitieren
APA
Zhou, C., Chen, D., Li, R., Li, Z., Ji, X., Teng, Y., Huai, X., Feng, B., & Song, J. (2026). Targeting Mitochondrial Complex I Protects Against Palmitic Acid–Induced Endothelial Dysfunction. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.71164
Vancouver
Zhou C, Chen D, Li R, Li Z, Ji X, Teng Y, et al. Targeting Mitochondrial Complex I Protects Against Palmitic Acid–Induced Endothelial Dysfunction. Diabetes, Obesity and Metabolism. 2026. doi:10.1111/dom.71164
BibTeX
@article{Zhou2026,
author = {Zhou, Chenxia and Chen, Da and Li, Ruoxuan and Li, Ziyi and Ji, Xinnan and Teng, Yiming and Huai, Xiaoyuan and Feng, Bo and Song, Jun},
title = {Targeting Mitochondrial Complex I Protects Against Palmitic Acid–Induced Endothelial Dysfunction},
journal = {Diabetes, Obesity and Metabolism},
year = {2026},
doi = {10.1111/dom.71164}
}
EUVIMED